MINNEAPOLIS - Medtronic, Inc. today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic ...
As clinicians have gained experience with transcatheter aortic valve implantation (TAVI) using the CoreValve system, the procedure has become safer—with fewer severe bleeds and cerebrovascular ...
Medtronic ($MDT) scored a pivotal CE mark that will help expand the market for its CoreValve transcatheter aortic valve replacement (TAVR). This latest regulatory nod ...
Natural aortic valves are subject to a great deal of physical stress. After decades, they can become stenosed or incompetent, but the prostheses that replace them end up being subjected to the same ...
SILVER SPRING, MD — The US Food and Drug Administration (FDA) has expanded the indication for the CoreValve System (Medtronic, Minneapolis, MN) to include aortic "valve-in-valve" replacement ...
Medtronic, Inc. 's ( MDT) CoreValve transcatheter aortic valve replacement (TAVR) system continues to provide efficient treatment at two years for extreme-risk patients, the company announced at the ...
Siegburg, Germany - Percutaneous implantation of the self-expanding CoreValve aortic valve bioprosthesis in the first-ever series of patients shows that the procedure is feasible in those deemed too ...
Medtronic announced Thursday that the company has received a CE Mark for valve-in-valve procedures using its CoreValve and CoreValve Evolut transcatheter aortic valve implantation system. It is the ...
The University of Michigan Frankel Cardiovascular Center is one of the first hospitals in the country to implant Medtronic's new investigational device during transcatheter aortic valve replacement ...
The Portneuf Medical Center is the first hospital in Idaho to replace a heart valve using the newest, cutting-edge technology known as the Medtronic CoreValve. This is different from the regular ...
The FDA has approved, for the first time, a transcathter heart valve for valve-in-valve (VIV) procedures in patients whose surgical aortic heart valves have failed. The agency expanded the approved ...
(Updated) The FDA has issued a warning letter to an investigator in the Medtronic CoreValve US Pivotal Trial. The letter cites numerous serious violations relating to the treatment of subjects in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results